TenaTac® - developing an advanced and cost-effective haemostat for the NHS
09 Nov 2021
Surgical Simulation Theatre
Surgical Simulation
Great innovations don’t always need to drive up procedure costs. TenaTac is a novel haemostat that addresses many of the limitations of existing products, whilst offering to reduce the cost burden on a pressurised NHS. Our data demonstrate that this CE-marked product is more effective than the market leader, whilst avoiding the risks of using blood derived products